Gland Pharma Ltd RHP
Registered Office : Sy No 143-148 150&151 Nr Gandi , X Roads D P Pally Dundigal , Hyderabad - 500043 , Telangana , India.
Phone : 91-40-30510999 Fax : 91-40-30510800
Email :investors@glandpharma.com Website : www.glandpharma.com
Initial public offer of 43196968 equity shares of face value of Re. 1 each (equity shares) of Gland Pharma Limited (Company or Issuer) for cash at a price of Rs.1500 Per equity share (including a share premium of Rs.1499 per equity share) aggregating Rs.6479.55 crores (The Offer) comprising a fresh issue of 8,333,333 equity shares aggregating up to Rs. 1250 crores on (The fresh issue) and an offer for sale of 34,863,635 equity shares, including 19,368,686 equity shares by Fosun Pharma Industrial Pte. Ltd (promoter selling shareholder) and 10,047,435 equity shares by Gland Celsus Bio Chemicals Private Limited, 3,573,014 equity shares By Empower Discretionary Trust, and 1,874,500 equity shares by Nilay Discretionary Trust (collectively, the other selling shareholders and collectively With the promoter selling shareholder are referred to as the selling shareholders, and such equity shares, the offered shares) aggregating up to Rs. 5229.55 crores (the offer for sale). The offer shall constitute 26.46% of the post-offer paid-up equity share capital of the company. The face value of Equity shares is Re.1 each. The offer price is Rs.1500 per equity share and is 1500 times the face value of the Equity Shares. The Anchor Investor Offer Price is Rs.1500 per Equity Share.
Issue | Money Payable On | ||
---|---|---|---|
Opens On | Closes On | Application | Allotment |
11/9/2020 12:00:00 AM | 11/11/2020 12:00:00 AM | Rs 1500 - 0 | Rs 0 - 0 |
Minimum Application for shares in Nos : 10 Further Multiples of : 10 | |||
Rs Cr | Lead Managers to the Issue | |
---|---|---|
Project Cost | 1250 | Citigroup Global Markets India Pvt Ltd |
Project Financed through Current Offer | 6479.55 | |
Post Issue Equity Share Capital | 1250 | |
Issue Price | Rs. 1500 |
Projects |
---|
Funding incremental working capital requirements of the company |
Promoted By | Listing At | Registrar to the Issue | ||
---|---|---|---|---|
| - | Link Intime India Pvt Ltd |
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.